PROJECT DETAILS
Optimal lung deposition of medication depends on the inbuilt resistance of the inhaler and the respiratory flow generated by the patient. Our client is a multinational conglomerate company based in London. Our collaboration has enabled them to analyze flow resistance in the dry powder inhaler for a range of inspiratory flow generated by patients from mild to severe chronic obstructive pulmonary disease. We employed precise CFD analysis practices to accurately capture the boundary layer and adopted meticulous verification steps to justify CFD analysis results. We delivered technically convincing CFD analysis results close to experimental values.
We Got More
Go through All Our Case Studies